PharmAla Completes Shipment of LaNeo™ MDMA to UCLA for Schizophrenia Study

PharmAla’s LaNeo™ MDMA, which remains the only commercially available MDMA drug product approved by the US Food and Drug Administration (USFDA) for clinical trial use, will be used in this case be used for a clinical trial investigating Schizophrenia.

Mdma made me pretty manic. Im surprised they focus on drugs like this for sz. Maybe to improve emotional range?

1 Like